Summary | |
---|---|
Symbol | DACT2 |
Name | dishevelled-binding antagonist of beta-catenin 2 |
Aliases | bA503C24.7; DAPPER2; C6orf116; chromosome 6 open reading frame 116; dapper homolog 2, antagonist of beta-cat ...... |
Chromosomal Location | 6q27 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | - |
Domain |
PF15268 Dapper |
Function |
Involved in regulation of intracellular signaling pathways during development. Negatively regulates the Nodal signaling pathway, possibly by promoting the lysosomal degradation of Nodal receptors, such as TGFBR1. May be involved in control of the morphogenetic behavior of kidney ureteric bud cells by keeping cells epithelial and restraining their mesenchymal character. May play an inhibitory role in the re-epithelialization of skin wounds by attenuating TGF-beta signaling (By similarity). |
Biological Process |
GO:0001655 urogenital system development GO:0001822 kidney development GO:0002064 epithelial cell development GO:0002244 hematopoietic progenitor cell differentiation GO:0003382 epithelial cell morphogenesis GO:0007162 negative regulation of cell adhesion GO:0007178 transmembrane receptor protein serine/threonine kinase signaling pathway GO:0016055 Wnt signaling pathway GO:0030111 regulation of Wnt signaling pathway GO:0032924 activin receptor signaling pathway GO:0032925 regulation of activin receptor signaling pathway GO:0032926 negative regulation of activin receptor signaling pathway GO:0038092 nodal signaling pathway GO:0043588 skin development GO:0072001 renal system development GO:0072044 collecting duct development GO:0072061 inner medullary collecting duct development GO:0090092 regulation of transmembrane receptor protein serine/threonine kinase signaling pathway GO:0090101 negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway GO:0198738 cell-cell signaling by wnt GO:1900107 regulation of nodal signaling pathway GO:1900108 negative regulation of nodal signaling pathway |
Molecular Function |
GO:0005080 protein kinase C binding GO:0008013 beta-catenin binding GO:0008134 transcription factor binding GO:0051018 protein kinase A binding GO:0070097 delta-catenin binding |
Cellular Component | - |
KEGG | - |
Reactome | - |
Summary | |
---|---|
Symbol | DACT2 |
Name | dishevelled-binding antagonist of beta-catenin 2 |
Aliases | bA503C24.7; DAPPER2; C6orf116; chromosome 6 open reading frame 116; dapper homolog 2, antagonist of beta-cat ...... |
Chromosomal Location | 6q27 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between DACT2 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | DACT2 |
Name | dishevelled-binding antagonist of beta-catenin 2 |
Aliases | bA503C24.7; DAPPER2; C6orf116; chromosome 6 open reading frame 116; dapper homolog 2, antagonist of beta-cat ...... |
Chromosomal Location | 6q27 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of DACT2 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | DACT2 |
Name | dishevelled-binding antagonist of beta-catenin 2 |
Aliases | bA503C24.7; DAPPER2; C6orf116; chromosome 6 open reading frame 116; dapper homolog 2, antagonist of beta-cat ...... |
Chromosomal Location | 6q27 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of DACT2 in various data sets.
|
Points in the above scatter plot represent the mutation difference of DACT2 in various data sets.
|
Summary | |
---|---|
Symbol | DACT2 |
Name | dishevelled-binding antagonist of beta-catenin 2 |
Aliases | bA503C24.7; DAPPER2; C6orf116; chromosome 6 open reading frame 116; dapper homolog 2, antagonist of beta-cat ...... |
Chromosomal Location | 6q27 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of DACT2. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | DACT2 |
Name | dishevelled-binding antagonist of beta-catenin 2 |
Aliases | bA503C24.7; DAPPER2; C6orf116; chromosome 6 open reading frame 116; dapper homolog 2, antagonist of beta-cat ...... |
Chromosomal Location | 6q27 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of DACT2. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by DACT2. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | DACT2 |
Name | dishevelled-binding antagonist of beta-catenin 2 |
Aliases | bA503C24.7; DAPPER2; C6orf116; chromosome 6 open reading frame 116; dapper homolog 2, antagonist of beta-cat ...... |
Chromosomal Location | 6q27 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of DACT2. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | DACT2 |
Name | dishevelled-binding antagonist of beta-catenin 2 |
Aliases | bA503C24.7; DAPPER2; C6orf116; chromosome 6 open reading frame 116; dapper homolog 2, antagonist of beta-cat ...... |
Chromosomal Location | 6q27 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of DACT2 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | DACT2 |
Name | dishevelled-binding antagonist of beta-catenin 2 |
Aliases | bA503C24.7; DAPPER2; C6orf116; chromosome 6 open reading frame 116; dapper homolog 2, antagonist of beta-cat ...... |
Chromosomal Location | 6q27 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between DACT2 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | DACT2 |
Name | dishevelled-binding antagonist of beta-catenin 2 |
Aliases | bA503C24.7; DAPPER2; C6orf116; chromosome 6 open reading frame 116; dapper homolog 2, antagonist of beta-cat ...... |
Chromosomal Location | 6q27 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting DACT2 collected from DrugBank database. |
There is no record. |